Skip to main content

NHLBI Microfluidic Devices Funding Opportunity

By December 11, 2013News
nhlbi-logo-new.png

nhlbi-logo-new.png

Development of a Microfluidic Platform for Blood Testing in Neonatal and Pediatric Patients STTR (R41) – RFA-HL-14-025

This FOA encourages applications to develop microfluidic devices to analyze blood for factors related to the thrombotic, transfusion, and/or hemostatic status of pediatric/neonatal patients. Platforms should support clinical and/or research applications. Microfluidic designs that are multifunctional, with the capacity to perform multiple assays on a single blood sample, are of interest. Use of these devices could significantly reduce levels of phlebotomy-induced blood loss in pediatric/neonatal patients.

Development of a Microfluidic Platform for Blood Testing in Neonatal and Pediatric Patients SBIR (R43/R44) – RFA-HL-14-026

This FOA encourages applications to develop microfluidic devices to analyze blood for factors related to the thrombotic, transfusion, and/or hemostatic status of pediatric/neonatal patients. Platforms should support clinical and/or research applications. Microfluidic designs that are multifunctional, with the capacity to perform multiple assays on a single blood sample, are of interest. Use of these devices could significantly reduce levels of phlebotomy-induced blood loss in pediatric/neonatal patients.

 

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.